Abstract 8980: Incremental Kidney and Glycemic Outcomes Associated with GLP-1 Receptor Agonist Plus SGLT2 Inhibitor Therapy versus SGLT2 Inhibitor Monotherapy in Adults with Type 2 Diabetes, Heart Failure and Chronic Kidney Disease
Background: Patients with type 2 diabetes mellitus (T2DM), heart failure (HF), and chronic kidney disease (CKD) remain at high risk for renal deterioration, glycaemic emergencies, and adverse cardiovascular outcomes despite contemporary therapy. Although sodium-glucose cotransporter-2 inhibitors (SGLT2i) improve car...